A critical advance in cancer research is occurring with the use of VHH fragments to re-engage dysfunctional p53. This essential tumor protector protein is frequently disabled in various types of cancer, leading https://fatallisto.com/story12110979/mini-antibodies-revive-the-p53-protein-the-promising-approach-for-cancer-therapy